Journal of Research in Ayurvedic Sciences

ORIGINAL ARTICLE
Year
: 2022  |  Volume : 6  |  Issue : 3  |  Page : 101--108

A clinical study to evaluate the efficacy of Ayurvedic intervention in management of chronic bronchitis


Rinku Tomar, Babita Yadav, Harbans Singh, Amin Hetalben, Shruti Khanduri, Bhagwan Sahay Sharma, Rakesh Rana, Richa Singhal, Bhogavalli Chandrasekhararao, Narayanam Srikanth, Kartar Singh Dhiman 
 Central Council for Research in Ayurvedic Sciences (CCRAS), Ministry of AYUSH, Govt. of India, New Delhi, India

Correspondence Address:
Dr. Amin Hetalben
Central Council for Research in Ayurvedic Sciences (CCRAS), Ministry of AYUSH, Govt. of India, D-Block, Janak Puri, New Delhi 110058
India

INTRODUCTION: Talisadi Churna (TC) is an Ayurveda formulation indicated in managing Kaphaja Kasa. The symptoms of Kaphaja Kasa, narrated in the Ayurveda classical texts, resembles with chronic bronchitis (CB). This open-label, single-arm, prospective study was planned to evaluate the efficacy of TC in the management of CB. MATERIALS AND METHODS: Seventy-five patients who fulfilled the inclusion criteria for CB were enrolled at Central Ayurveda Research Institute for Respiratory Disorders, Patiala. They were treated by oral administration of TC 3 gm thrice a day for 12 weeks with a post-treatment follow-up after four weeks. The results were assessed by change in Leicester Cough Questionnaire (LCQ) Score, episodes of acute exacerbation, change in St. George’s Respiratory Questionnaire (SGRQ) Score for Quality-of-life, Functional/Exercise capacity [change in peak expiratory flow rate (PEFR) and FEV1%] and occurrence of adverse events. RESULTS: Sixty-eight participants completed the study. Significant results (P < 0.001) is found in wheezing, nausea, etc and in the cardinal symptoms such as breathlessness, cough, and expectoration. Statistically significant changes were found in LCQ, SGRQ, and PEFR parameters. No adverse events were reported during the study period. CONCLUSION: Talisadi Churna may be found effective in conditions such as Chronic Bronchitis. Based on the promising results of this study, randomized controlled trials with adequate sample size may be planned on Talisadi Churna in Chronic Bronchitis compared to standard care or as an add-on therapy with conventional medicine. Therefore TC can be further evaluated for incorporating it under the standard measure for management of CB.


How to cite this article:
Tomar R, Yadav B, Singh H, Hetalben A, Khanduri S, Sharma BS, Rana R, Singhal R, Chandrasekhararao B, Srikanth N, Dhiman KS. A clinical study to evaluate the efficacy of Ayurvedic intervention in management of chronic bronchitis.J Res Ayurvedic Sci 2022;6:101-108


How to cite this URL:
Tomar R, Yadav B, Singh H, Hetalben A, Khanduri S, Sharma BS, Rana R, Singhal R, Chandrasekhararao B, Srikanth N, Dhiman KS. A clinical study to evaluate the efficacy of Ayurvedic intervention in management of chronic bronchitis. J Res Ayurvedic Sci [serial online] 2022 [cited 2022 Dec 7 ];6:101-108
Available from: http://www.jrasccras.com/article.asp?issn=2456-5601;year=2022;volume=6;issue=3;spage=101;epage=108;aulast=Tomar;type=0